http://health.law360.com/ The Newswire for Legal Professionals Copyright 2009 Portfolio Media, Inc. en-US http://health.law360.com/images/headings/logo.gif http://health.law360.com/ http://health.law360.com/articles/135319 A federal appeals court has ruled that the federal Rehabilitation Act covers discrimination claims brought by an independent contractor, siding against a medical center that allegedly failed to accommodate an anesthesiologist with sickle cell anemia. http://health.law360.com/articles/135319 http://health.law360.com/articles/135410 A federal judge has reinstated allegations that Buffalo, N.Y.'s two major hospital systems violated state labor law by failing to pay employees for work they performed before and after their shifts. http://health.law360.com/articles/135410 http://health.law360.com/articles/135427 MvuInvestors LLC has appealed its recent loss to General Electric Co. unit GE Healthcare in their dispute over GE’s aborted deal to acquire Mvu’s MRI technology. http://health.law360.com/articles/135427 http://health.law360.com/articles/135516 Procter & Gamble Co. has recalled 120,000 bottle of Vicks Sinex nasal spray due to possible bacterial contamination. http://health.law360.com/articles/135516 http://health.law360.com/articles/135395 Teva Pharmaceuticals USA Inc., having come out on the losing end in a three-year infringement struggle with Alcon Inc. over a patent related to the anti-bacterial eye drop drug Vigamox, has said it will keep up the fight in an appeal to the U.S. Court of Appeals for the Federal Circuit. http://health.law360.com/articles/135395 http://health.law360.com/articles/135389 Exela PharmSci Pvt. Ltd. wants a federal appeals court to review a decision that the India-based drugmaker's proposed generic version of Allergan Inc.’s glaucoma treatment Alphagan infringed a patent. http://health.law360.com/articles/135389 http://health.law360.com/articles/135354 A jury has convicted the ex-chairman of McKesson Corp. on several counts of securities fraud handed down in the wake of a $9 billion accounting scandal at the health care firm but has let the firm's former general counsel off the hook. http://health.law360.com/articles/135354 http://health.law360.com/articles/135318 A federal appeals court on Thursday struck down infringement claims for a bodybuilding supplement patent held by Iovate Health Sciences Inc. and the University of Florida Research Foundation, ruling that certain fitness magazine ads describing the product had rendered the patent obvious. http://health.law360.com/articles/135318 http://health.law360.com/articles/135349 A unit of St. Jude Medical Inc. has won a preliminary injunction against a former employee who allegedly stole trade secrets in order to set up a rival medical device company in China, according to attorneys representing St. Jude. http://health.law360.com/articles/135349 http://health.law360.com/articles/135307 A jury has sided with Novartis AG in a suit it filed claiming Teva Pharmaceuticals USA Inc. infringed the patent for its genital herpes drug Famvir by seeking regulatory approval to market its own generic version. http://health.law360.com/articles/135307 http://health.law360.com/articles/135300 U.S. Senate Majority Leader Harry Reid of Nevada is pushing forward with plans for a vote this weekend that would allow the higher chamber of Congress to begin considering the Democrats' $848 billion proposed overhaul of the U.S. health care system. http://health.law360.com/articles/135300 http://health.law360.com/articles/135149 Athena Diagnostics Inc., the sublicensee of patents related to genetic tests for the detection and diagnosis of certain forms of diabetes, has accused rival laboratory Ambry Genetics Corp. of infringing four of those patents in its testing. http://health.law360.com/articles/135149 http://health.law360.com/articles/135182 A post-trial battle over damages has erupted between I-Flow Corp. and Apex Medical Technologies Inc., following a federal jury's finding that Apex and one of its principals should pay about $13 million for infringing an I-Flow patent for a medical infusion pump. http://health.law360.com/articles/135182 http://health.law360.com/articles/135185 The head of the European Commission's pharmaceutical task force reportedly told drug companies Thursday of plans to ask for details on patent deals with generic-drug makers that are suspected of delaying the entry of cheaper drugs into the market. http://health.law360.com/articles/135185 http://health.law360.com/articles/135173 Ordered to arbitrate its dispute with Citigroup Inc.’s brokerage division over the sale of $41 million of worthless auction rate securities, Braintree Laboratories Inc. is trying to avoid holding the proceeding before a Financial Industry Regulatory Authority panel that the plaintiff says favors the accused. http://health.law360.com/articles/135173 http://health.law360.com/articles/135249 OraSure Technologies Inc. has agreed to hand over $3 million to Inverness Medical Switzerland GmbH and Church & Dwight Co. Inc., putting an end to a patent infringement dispute over HIV antibody tests. http://health.law360.com/articles/135249 http://health.law360.com/articles/135122 Karen B. Dow, a biotechnology and pharmaceutical patent attorney who formerly was patent counsel for Eli Lilly & Co., has joined intellectual property firm Sughrue Mion PLLC. http://health.law360.com/articles/135122 http://health.law360.com/articles/135075 A federal appeals court has found that Cell Therapeutics Inc.’s settlement of a qui tam suit should not preclude it from bringing suit seeking contractual indemnification from its reimbursement consultant for damages as part of the government’s investigation over its leukemia treatment Trisonex. http://health.law360.com/articles/135075 http://health.law360.com/articles/135119 More than a hundred Democratic members of the U.S. Senate and the House of Representatives called on the health insurance industry Wednesday to respond to allegations that insurers are planning steep premium rate hikes in 2010 in anticipation of health care reform legislation. http://health.law360.com/articles/135119 http://health.law360.com/articles/135054 The U.S. Food and Drug Administration has announced labeling changes to Plavix, manufactured by Sanofi-Aventis SA and Bristol-Myers Squibb Co., to reflect new data showing that simultaneously taking the heartburn treatment Prilosec can sharply reduce the effects of the blockbuster blood thinner. http://health.law360.com/articles/135054